Advertisement

Topics

Chromosomal Abnormality May Hold Promise in Treating AML

06:25 EDT 15 Sep 2018 | Cancer Networks

Although the study found lurbinectedin isn't promising, the presence of a chromosomal 11q21-23 abnormality may open doors in treating the disease.

Original Article: Chromosomal Abnormality May Hold Promise in Treating AML

NEXT ARTICLE

More From BioPortfolio on "Chromosomal Abnormality May Hold Promise in Treating AML"

Advertisement
Quick Search
Advertisement
Advertisement